145 related articles for article (PubMed ID: 26297642)
41. Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model.
Chen QH; Zhou WD; Su ZY; Huang QS; Jiang JN; Chen QX
Fertil Steril; 2010 Mar; 93(5):1448-54. PubMed ID: 19342044
[TBL] [Abstract][Full Text] [Related]
42. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
[TBL] [Abstract][Full Text] [Related]
43. The effects of ulipristal on Bax/Bcl-2, cytochrome c, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis.
Huniadi CA; Pop OL; Antal TA; Stamatian F
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):360-5. PubMed ID: 23619346
[TBL] [Abstract][Full Text] [Related]
44. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis.
Hudelist G; Keckstein J; Czerwenka K; Lass H; Walter I; Auer M; Wieser F; Wenzl R; Kubista E; Singer CF
Fertil Steril; 2005 Oct; 84 Suppl 2():1249-56. PubMed ID: 16210018
[TBL] [Abstract][Full Text] [Related]
45. Growth mechanisms of endometriotic cells in implanted places: a review.
Jiang QY; Wu RJ
Gynecol Endocrinol; 2012 Jul; 28(7):562-7. PubMed ID: 22296665
[TBL] [Abstract][Full Text] [Related]
46. Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model.
González-Ramos R; Van Langendonckt A; Defrère S; Lousse JC; Mettlen M; Guillet A; Donnez J
Gynecol Obstet Invest; 2008; 65(3):174-86. PubMed ID: 18025832
[TBL] [Abstract][Full Text] [Related]
47. A priori implantation potential does not differ in eutopic endometrium of patients with and without endometriosis.
Gescher DM; Siggelkow W; Meyhoefer-Malik A; Malik E
Arch Gynecol Obstet; 2005 Jul; 272(2):117-23. PubMed ID: 15986219
[TBL] [Abstract][Full Text] [Related]
48. Quantitative assessment of human endometriotic tissue maintenance and regression in a noninvasive mouse model of endometriosis.
Fortin M; Lépine M; Merlen Y; Thibeault I; Rancourt C; Gosselin D; Hugo P; Steff AM
Mol Ther; 2004 Apr; 9(4):540-7. PubMed ID: 15093184
[TBL] [Abstract][Full Text] [Related]
49. Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect.
Zhang ZZ; Hu CP; Tang WW; Gui T; Qian RY; Xing YX; Cao P; Wan GP
Climacteric; 2013 Dec; 16(6):700-8. PubMed ID: 23394299
[TBL] [Abstract][Full Text] [Related]
50. Effect of recombinant human endostatin on endometriosis in mice.
Jiang HQ; Li YL; Zou J
Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
[TBL] [Abstract][Full Text] [Related]
51. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats.
Ergenoğlu AM; Yeniel AÖ; Erbaş O; Aktuğ H; Yildirim N; Ulukuş M; Taskiran D
Reprod Sci; 2013 Oct; 20(10):1230-6. PubMed ID: 23536571
[TBL] [Abstract][Full Text] [Related]
52. Peritoneal endometriosis: validation of an in-vivo model.
Grümmer R; Schwarzer F; Bainczyk K; Hess-Stumpp H; Regidor PA; Schindler AE; Winterhager E
Hum Reprod; 2001 Aug; 16(8):1736-43. PubMed ID: 11473975
[TBL] [Abstract][Full Text] [Related]
53. The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.
Olivares C; Ricci A; Bilotas M; Barañao RI; Meresman G
Fertil Steril; 2011 Aug; 96(2):428-33. PubMed ID: 21683949
[TBL] [Abstract][Full Text] [Related]
54. In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy.
Laschke MW; Elitzsch A; Vollmar B; Menger MD
Fertil Steril; 2005 Oct; 84 Suppl 2():1199-209. PubMed ID: 16210012
[TBL] [Abstract][Full Text] [Related]
55. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
Xu H; Zhang T; Man GC; May KE; Becker CM; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wong AW; Wang CC
Angiogenesis; 2013 Jul; 16(3):541-51. PubMed ID: 23334337
[TBL] [Abstract][Full Text] [Related]
56. Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment.
Khoufache K; Bondza PK; Harir N; Daris M; Leboeuf M; Mailloux J; Lemyre M; Foster W; Akoum A
Am J Pathol; 2012 Oct; 181(4):1197-205. PubMed ID: 22841820
[TBL] [Abstract][Full Text] [Related]
57. Regression of endometrial autografts in a rat model of endometriosis treated with etanercept.
Islimye M; Kilic S; Zulfikaroglu E; Topcu O; Zergeroglu S; Batioglu S
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):184-9. PubMed ID: 21741153
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of estrogen treatment in an immunodeficient mouse endometriosis model.
Colette S; Defrère S; Lousse JC; Van Langendonckt A; Loumaye E; Donnez J
Gynecol Obstet Invest; 2009; 68(4):262-8. PubMed ID: 19776614
[TBL] [Abstract][Full Text] [Related]
59. Antiangiogenic agents are effective inhibitors of endometriosis.
Hull ML; Charnock-Jones DS; Chan CL; Bruner-Tran KL; Osteen KG; Tom BD; Fan TP; Smith SK
J Clin Endocrinol Metab; 2003 Jun; 88(6):2889-99. PubMed ID: 12788903
[TBL] [Abstract][Full Text] [Related]
60. Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue.
Lee KF; Lee YL; Chan RW; Cheong AW; Ng EH; Ho PC; Yeung WS
Fertil Steril; 2010 Mar; 93(4):1052-60. PubMed ID: 19135668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
